Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Ventyx Biosciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $394.49M | $394.49M - $394.49M | $0.00 | $0.09 | 2 |
| Dec 2028 | $267.26M | $267.26M - $267.26M | $0.00 | -$0.551 | 5 |
| Dec 2027 | $30.57M | $30.57M - $30.57M | $0.00 | -$1.599 | 5 |
| Dec 2026 | $13.10M | $13.10M - $13.10M | $0.00 | -$1.767 | 6 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.469 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.096 | 0 |